- Home
- LSF vs COCH Comparison
LSF vs COCH Comparison
Compare LSF & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LSF | COCH |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Blank Checks |
| Sector | Consumer Staples | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 20.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | LSF | COCH |
|---|---|---|
| Price | $2.31 | $0.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $9.50 |
| AVG Volume (30 Days) | 118.3K | ★ 483.9K |
| Earning Date | 11-10-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $48,146,862.00 | $208,000.00 |
| Revenue This Year | $18.05 | N/A |
| Revenue Next Year | $17.53 | $29.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.73 | N/A |
| 52 Week Low | $2.18 | $0.64 |
| 52 Week High | $8.99 | $2.27 |
Technical Indicators
Market Signals| Indicator | LSF | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 28.90 | 56.45 |
| Support Level | $2.18 | $0.79 |
| Resistance Level | $2.78 | $0.87 |
| Average True Range (ATR) | 0.19 | 0.06 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 27.67 | 86.06 |
Price Performance
Historical ComparisonAbout LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.